Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
Health insurance company Humana (NYSE:HUM) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 11.4% year on year to $32.52 billion. Its GAAP loss of $6.61 per share was 62.2% below analysts’ consensus estimates.
Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share (EPS) for the quarter ended December 31, 2025 (4Q25) versus the quarter ended December 31 31, 2024 (4Q24) and for the year ended December 31, 2025 (FY 2025) versus the year ended December 31, 2024 (FY 2024) as noted in the tables below.
Shares of insurance brokerage firm Arthur J. Gallagher (NYSE:AJG) fell 9.4% in the afternoon session after OpenAI launched a suite of insurance-native applications within its ChatGPT App Library, posing a direct threat to the traditional brokerage model.
The healthcare landscape in early 2026 is defined by a shift from unrestrained growth to tactical consolidation. At the center of this transition sits UnitedHealth Group (NYSE: UNH), a behemoth that has navigated a tumultuous 24 months marked by massive cyber-disruptions, leadership overhauls, and intensifying federal scrutiny. Today, February 9, 2026, the company finds itself [...]
The managed care sector was sent into a tailspin on Friday as Molina Healthcare (NYSE: MOH) saw its market capitalization evaporate in a historic sell-off. Shares of the Long Beach-based insurer plummeted 28% to $127.16 after the company issued a 2026 earnings forecast that was not just a miss,
Michael Burry says he’s happy with MOH stock, even as Molina Healthcare stock crumbles 25% on disappointing guidance. But are MOH shares really worth buying today?
In a week defined by high-stakes political theater and a brief but disruptive lapse in federal operations, Washington has managed to pull back from the edge of a total collapse—though only partially. On February 3, 2026, a $1.2 trillion appropriations package was signed into law, ending a four-day
Hitting a new 52-week low can be a pivotal moment for any stock.
These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
Humana Inc. (NYSE: HUM), a health and well-being company focused on helping people live their healthiest lives, today released its latest Value-Based Care By the Numbers Report. The findings show that value-based care helps Medicare Advantage patients receive more personalized, preventive care while improving their overall health experience.
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
What a brutal six months it’s been for Humana. The stock has dropped 20.9% and now trades at $195.56, rattling many shareholders. This might have investors contemplating their next move.
